As U.S. relations with Cuba thaw, one unexpected byproduct could be the introduction of a Cuban-developed lung cancer
vaccine in the U.S. Called Cimavax, an innovative vaccine that was
developed to help treat lung cancer patients in Cuba, where lung cancer
is one of the leading causes of death.
The immunotherapy treatment could be coming to the U.S. thanks in part
to the Roswell Park Cancer Institute in Buffalo, New York, which is
working with Cuba's Center for Molecular Immunology to bring the
treatment to the U.S.
ABC News spoke to Dr. Kelvin Lee, the chairman of the Department of
Immunology at the Roswell Park Cancer Institute, to learn more about the
new medication.
What is Cimavax?
Cimavax is a vaccine designed by Cuba’s Center for Molecular Immunology
to help lung cancer patients by targeting a specific hormone that can
encourage tumors to grow. The vaccine works by creating a protein in the
body that primes the immune system to attack a hormone called epidermal
growth factor (EGF), a naturally occurring hormone in the body.
To See the full article: http://abcnews.go.com/Health/cuban-developed-lung-cancer-vaccine-arrive-us/story?id=30995009
Related Blogger Health News: http://www.nickblogger.com/blog/?category=Health+and+Well+Being
No comments:
Post a Comment